Skip to main content
ARVN logo

Arvinas, Inc.

ARVNNASDAQHealthcareBiotechnology

$7.30Today:- (-)1Y −15.72%

As of Oct 23, 2026 close

Market cap
$479.61M
P/E (TTM)
51.57
Forward P/E
-
Dividend yield
-
52-week range
$6.74$14.51
Volume (live)
-
Avg. volume (3M)
824.68K

Arvinas, Inc. (ARVN) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Arvinas, Inc. stock.

Analyst Consensus Rating

Investment consensus from 13 professional research analysts

Consensus Rating

Buy
Based on 13 unique analysts
(16 total ratings in last 90 days)
High Confidence∞:1 Buy/Sell

Average Price Target

$15.07
+106.44% upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest ARVN Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Zacks Equity Research
Zacks Equity Research
BuyInitiates Coverage
-
Robert Driscoll
Wedbush
HoldMaintains
$12.00
Tazeen Ahmad
BofA Securities
HoldMaintains
$16.00
Zacks Equity Research
Zacks Equity Research
HoldInitiates Coverage
-
Edward Tenthoff
Piper Sandler
BuyReiterates
$10.00 → $20.00
Edmund Ingham
Forbes
BuyInitiates Coverage
-
Srikripa Devarakonda
Truist
HoldReiterates
$8.68
Yigal Nochomovitz
Citi
BuyMaintains
$24.00 → $21.00
Jonathan Miller
Evercore ISI Group
BuyReiterates
$19.00 → $14.00
Terence Flynn
Morgan Stanley
HoldReiterates
$11.00 → $10.00
Tazeen Ahmad
BofA Securities
HoldMaintains
-
Robert Driscoll
Wedbush
HoldMaintains
$11.00 → $12.00
Andrew Fein
HC Wainwright
BuyMaintains
$18.00
Etzer Darout
Barclays
BuyMaintains
$20.00
Derek Archila
Wells Fargo
HoldUpgrades
$15.00 → $11.00
Nicholas Lorusso
TD Cowen
HoldMaintains
-

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 16, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for ARVN?

The analyst consensus rating for ARVN is Buy, based on the latest ratings from 13 analysts over the last 90 days.

What is the average price target for ARVN?

The average 12-month price target for ARVN is $15.07, representing an upside of 106.4% from the Oct 23, 2026 close of $7.30.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.